scientific-skills/markdown-mermaid-writing/assets/examples/example-research-report.md
Example research report — demonstrates markdown-mermaid-writing skill standards. All diagrams use Mermaid embedded in markdown as the source format.
This report analyzes the efficiency of CRISPR-Cas9 gene editing across three cell line models under variable guide RNA (gRNA) conditions. Editing efficiency was quantified by T7E1 assay and next-generation sequencing (NGS) of on-target loci1.
Key findings:
CRISPR editing experiments followed a standardized five-stage protocol. Each stage has defined go/no-go criteria before proceeding.
flowchart TD
accTitle: CRISPR Editing Experimental Workflow
accDescr: Five-stage experimental pipeline from gRNA design through data analysis, with quality checkpoints between each stage.
design["🧬 Stage 1
gRNA Design
(CRISPRscan + Cas-OFFinder)"]
synth["⚙️ Stage 2
Oligo Synthesis
& Annealing"]
transfect["🔬 Stage 3
Cell Transfection
(Lipofectamine 3000)"]
screen["🧪 Stage 4
Primary Screen
(T7E1 assay)"]
ngs["📊 Stage 5
NGS Validation
(150 bp PE reads)"]
qc1{GC 40-65%?}
qc2{Yield ≥ 2 µg?}
qc3{Viability ≥ 85%?}
qc4{Band visible?}
design --> qc1
qc1 -->|"✅ Pass"| synth
qc1 -->|"❌ Redesign"| design
synth --> qc2
qc2 -->|"✅ Pass"| transfect
qc2 -->|"❌ Re-synthesize"| synth
transfect --> qc3
qc3 -->|"✅ Pass"| screen
qc3 -->|"❌ Optimize"| transfect
screen --> qc4
qc4 -->|"✅ Pass"| ngs
qc4 -->|"❌ Repeat"| screen
classDef stage fill:#dbeafe,stroke:#2563eb,stroke-width:2px,color:#1e3a5f
classDef gate fill:#fef9c3,stroke:#ca8a04,stroke-width:2px,color:#713f12
classDef fail fill:#fee2e2,stroke:#dc2626,stroke-width:2px,color:#7f1d1d
class design,synth,transfect,screen,ngs stage
class qc1,qc2,qc3,qc4 gate
Three cell lines were used: HEK293T (human embryonic kidney), K562 (chronic myelogenous leukemia), and Jurkat (T-lymphocyte). All lines were maintained in RPMI-1640 with 10% FBS at 37°C / 5% CO₂2.
gRNAs targeting the EMX1 locus were designed using CRISPRscan3 with the following criteria:
| Criterion | Threshold | Rationale |
|---|---|---|
| GC content | 40–65% | Optimal Tm and Cas9 binding |
| CRISPRscan score | ≥ 0.6 | Predicted on-target activity |
| Off-target sites | ≤ 5 (≤3 mismatches) | Reduce off-target editing risk |
| Homopolymer runs | None (>4 nt) | Prevents premature transcription stop |
RNP complexes were assembled at 1:1.2 molar ratio (Cas9:gRNA) and delivered by lipofection. Cells were harvested 72 hours post-transfection for genomic DNA extraction.
sequenceDiagram
accTitle: NGS Data Analysis Pipeline
accDescr: Sequence of computational steps from raw FASTQ files through variant calling to final efficiency report.
participant raw as 📥 Raw FASTQ
participant qc as 🔍 FastQC
participant trim as ✂️ Trimmomatic
participant align as 🗺️ BWA-MEM2
participant call as ⚙️ CRISPResso2
participant report as 📊 Report
raw->>qc: Per-base quality scores
qc-->>trim: Flag low-Q reads (Q<20)
trim->>align: Cleaned reads
align->>align: Index reference genome (hg38)
align->>call: BAM + target region BED
call->>call: Quantify indel frequency
call-->>report: Editing efficiency (%)
call-->>report: Off-target events
report-->>report: Statistical summary
| Cell line | n (replicates) | Mean efficiency (%) | SD (%) | Range (%) |
|---|---|---|---|---|
| HEK293T | 6 | 78.4 | 4.2 | 71.2–84.6 |
| K562 | 6 | 52.1 | 8.7 | 38.4–63.2 |
| Jurkat | 6 | 31.8 | 11.3 | 14.2–47.5 |
HEK293T cells showed significantly higher editing efficiency than both K562 (p < 0.001) and Jurkat (p < 0.001) lines by one-way ANOVA with Tukey post-hoc correction.
GC content between 40–65% was strongly correlated with editing efficiency (Pearson r = 0.82, p < 0.0001, n = 48 gRNAs).
xychart-beta
accTitle: Editing Efficiency vs gRNA GC Content
accDescr: Bar chart showing mean editing efficiency grouped by GC content bins, demonstrating optimal performance in the 40 to 65 percent GC range
title "Mean Editing Efficiency by GC Content Bin (HEK293T)"
x-axis ["< 30%", "30–40%", "40–50%", "50–65%", "> 65%"]
y-axis "Editing Efficiency (%)" 0 --> 100
bar [18, 42, 76, 81, 38]
timeline
accTitle: Experiment Timeline — CRISPR Efficiency Study
accDescr: Chronological milestones from study design through manuscript submission across six months
section Month 1
Study design and gRNA library design : 48 gRNAs across 3 target loci
Cell line authentication : STR profiling confirmed all three lines
section Month 2
gRNA synthesis and QC : 46/48 gRNAs passed yield threshold
Pilot transfections (HEK293T) : Optimized lipofection conditions
section Month 3
Full transfection series : All 3 cell lines, all 46 gRNAs, 6 replicates
T7E1 primary screening : Passed go/no-go for all conditions
section Month 4
NGS library preparation : 276 samples processed
Sequencing run (NovaSeq) : 150 bp PE, mean 50k reads/sample
section Month 5
Bioinformatic analysis : CRISPResso2 pipeline
Statistical analysis : ANOVA, correlation, regression
section Month 6
Manuscript preparation : This report
HEK293T's superior editing efficiency relative to K562 and Jurkat likely reflects three factors4:
Off-target editing was assessed by GUIDE-seq at the 5 highest-activity gRNAs. No off-target sites exceeding 0.1% editing frequency were detected. The three potential sites flagged by Cas-OFFinder (≤2 mismatches) showed 0.00%, 0.02%, and 0.04% indel frequencies — all below the assay noise floor of 0.05%.
Full GUIDE-seq data available in supplementary data package (GEO accession pending).
</details>Radar chart comparing three CRISPR delivery methods across five performance dimensions. Note: Radar charts do not support accTitle/accDescr — description provided above.
radar-beta
title Performance vs. Published Methods
axis eff["Efficiency"], spec["Specificity"], del["Delivery ease"], cost["Cost"], viab["Cell viability"]
curve this_study["This study (RNP + Lipo)"]{78, 95, 80, 85, 90}
curve plasmid["Plasmid Cas9 (lit.)"]{55, 70, 90, 95, 75}
curve electroporation["Electroporation RNP (lit.)"]{88, 96, 50, 60, 65}
max 100
graticule polygon
ticks 5
showLegend true
Ran, F.A. et al. (2013). "Genome engineering using the CRISPR-Cas9 system." Nature Protocols, 8(11), 2281–2308. https://doi.org/10.1038/nprot.2013.143 ↩
ATCC. (2024). "Cell Line Authentication and Quality Control." https://www.atcc.org/resources/technical-documents/cell-line-authentication ↩
Moreno-Mateos, M.A. et al. (2015). "CRISPRscan: designing highly efficient sgRNAs for CRISPR-Cas9 targeting in vivo." Nature Methods, 12(10), 982–988. https://doi.org/10.1038/nmeth.3543 ↩
Molla, K.A. & Yang, Y. (2019). "CRISPR/Cas-Mediated Base Editing: Technical Considerations and Practical Applications." Trends in Biotechnology, 37(10), 1121–1142. https://doi.org/10.1016/j.tibtech.2019.03.008 ↩